Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹372 Cr
up ₹90.7 Cr vs Mar 2020
- Stocks held
- 24
- up 1 vs Mar 2020
- Top 10 weight
- 59.3%
- of the portfolio in its ten largest
- Cash & debt
- 5.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 2
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In April 2020 it disclosed 24 stocks worth ₹372 Cr, up ₹90.7 Cr from Mar 2020. Its largest positions were IPCA Laboratories Limited (10.1%), Dr. Reddy's Laboratories Limited (9.6%), JB Chemicals & Pharmaceuticals Limited (8.4%); the ten largest together made up 59.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 70.7% of its equity. Cash and debt stood at 5.5%. Compared with Mar 2020 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
82%
Top-10 weight is higher than 82% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
75%
Holds more cash than 75% of peers
What these mean: concentration · cash
Holdings in April 2020
Download CSVEvery line the fund disclosed, with the change against Mar 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| IPCA Laboratories Limited | 10.09% | down 0.12 pts | ₹37.5 Cr | up ₹8.8 Cr | Added |
| Dr. Reddy's Laboratories Limited | 9.62% | down 0.16 pts | ₹35.8 Cr | up ₹8.3 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 8.36% | up 0.67 pts | ₹31.1 Cr | up ₹9.5 Cr | Added |
| Divi's Laboratories Limited | 7.45% | down 0.95 pts | ₹27.7 Cr | up ₹4.1 Cr | Added |
| Cash, TREPS & receivables | 5.53% | up 0.96 pts | ₹20.6 Cr | up ₹7.7 Cr | Added |
| Indoco Remedies Limited | 4.71% | down 0.39 pts | ₹17.5 Cr | up ₹3.2 Cr | Added |
| Sun Pharmaceutical Industries Limited | 4.30% | down 0.01 pts | ₹16 Cr | up ₹3.9 Cr | Added |
| Torrent Pharmaceuticals Limited | 3.79% | up 0.59 pts | ₹14.1 Cr | up ₹5.1 Cr | Added |
| Procter & Gamble Health Limited | 3.72% | down 0.42 pts | ₹13.8 Cr | up ₹2.2 Cr | Added |
| Alembic Pharmaceuticals Limited | 3.69% | up 0.45 pts | ₹13.7 Cr | up ₹4.6 Cr | Added |
| Ajanta Pharma Limited | 3.57% | up 0.36 pts | ₹13.3 Cr | up ₹4.2 Cr | Added |
| Jubilant Pharmova Limited | 3.31% | up 1.64 pts | ₹12.3 Cr | up ₹7.6 Cr | Added |
| Alkem Laboratories Limited | 3.25% | up 0.39 pts | ₹12.1 Cr | up ₹4 Cr | Added |
| Abbott Laboratories | 3.09% | down 0.44 pts | ₹11.5 Cr | up ₹1.6 Cr | Added |
| Abbott India Limited | 3.01% | down 0.46 pts | ₹11.2 Cr | up ₹1.4 Cr | Added |
| Dr. Lal Path Labs Limited | 2.69% | down 0.45 pts | ₹10 Cr | up ₹1.2 Cr | Added |
| Aarti Drugs Limited | 2.60% | up 0.47 pts | ₹9.7 Cr | up ₹3.7 Cr | Added |
| Narayana Hrudayalaya Limited | 2.54% | down 0.43 pts | ₹9.5 Cr | up ₹1.1 Cr | Added |
| Syngene International Limited | 2.48% | up 0.03 pts | ₹9.2 Cr | up ₹2.3 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.27% | up 0.31 pts | ₹8.5 Cr | up ₹2.9 Cr | Added |
| Max India Limited | 2.25% | down 0.70 pts | ₹8.4 Cr | up ₹7 L | Added |
| Apollo Hospitals Enterprise Limited | 2.23% | down 1.77 pts | ₹8.3 Cr | down ₹3 Cr | Trimmed |
| Abiomed Inc | 2.22% | down 0.37 pts | ₹8.3 Cr | up ₹96 L | Added |
| Unichem Laboratories Limited | 1.73% | down 0.68 pts | ₹6.4 Cr | down ₹33 L | Trimmed |
| Intuitive Surgical Inc | 1.49% | up 1.49 pts | ₹5.5 Cr | up ₹5.5 Cr | New |
What changed, Mar 2020 to Apr 2020
New New positions (1)
- Intuitive Surgical Inc1.5% · ₹5.5 Cr
Exited Exited (0)
None.
Added Biggest additions
- JB Chemicals & Pharmaceuticals Limitedup ₹9.5 Cr (+0.67% pts)
- IPCA Laboratories Limitedup ₹8.8 Cr (−0.12% pts)
- Dr. Reddy's Laboratories Limitedup ₹8.3 Cr (−0.16% pts)
- Jubilant Pharmova Limitedup ₹7.6 Cr (+1.64% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2020, the weight rose most in Pharmaceuticals & Biotechnology (+3.3 pts) and Healthcare Equipment & Supplies (+1.6 pts), and fell most in Healthcare Services (−3.7 pts) and Pharmaceuticals (−1.5 pts).
- Pharmaceuticals & Biotechnology67.4% → 70.7%+3.3 pts
- Healthcare Equipment & Supplies0.0% → 1.6%new+1.6 pts
- Insurance2.1% → 2.4%+0.3 pts
- Healthcare Services19.0% → 15.3%−3.7 pts
- Pharmaceuticals11.6% → 10.1%−1.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2019 | Oct 2019 | Jan 2020 | Mar 2020 | Apr 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.3% | 68.5% | 65.6% | 67.4% | 70.7% |
| Healthcare Services | 14.8% | 18.9% | 21.6% | 19.0% | 15.3% |
| Pharmaceuticals | 12.6% | 11.0% | 11.4% | 11.6% | 10.1% |
| Insurance | 2.3% | 1.6% | 1.4% | 2.1% | 2.4% |
| Healthcare Equipment & Supplies | — | — | — | — | 1.6% |
Allocation in Apr 2020change vs Mar 2020
- Pharmaceuticals & Biotechnology (13)70.7%▲ 3.3 pts
- Healthcare Services (6)15.3%▼ 3.7 pts
- Pharmaceuticals (3)10.1%▼ 1.5 pts
- Insurance (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Apr 2020
5.5%
▲ 1.0 pts vs Mar 2020
- Cash alone
- 5.5%
- cash and net receivables
- A year earlier
- 6.5%
- Apr 2019 · now ▼ 1.0 pts
- Last 12 months
- 1.7% – 5.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.